Gentium S.p.A. today announced that it has requested a re-examination of the negative opinion adopted, by the European Medicines Agency's Committee for Medicinal Products for Human Use , on March 22nd, regarding the Marketing Authorisation submitted for Defibrotide to treat and prevent hepatic veno-occlusive disease in adults and children ... (more)
http://www.benzinga.com/news/13/04/3499604/gentium-requests-re-examination-of-negative-chmp-opinion-on-defibrotide
http://www.benzinga.com/news/13/04/3499604/gentium-requests-re-examination-of-negative-chmp-opinion-on-defibrotide
No comments:
Post a Comment